IC41

BIOLOGICAL2 trials

Sponsors

Valneva Austria GmbH

Conditions

Chronic Hepatitis C

Phase 2

Virological Response Study of the HCV Vaccine IC41

CompletedNCT00601770

Valneva Austria GmbHChronic Hepatitis C

Start: 2006-02-28End: 2008-07-31Updated: 2014-02-11

Phase II Study of Immunization With a Hepatitis C Virus (HCV) Antigen Peptide Vaccine

CompletedNCT00602784

Valneva Austria GmbHChronic Hepatitis C

Start: 2002-11-30End: 2004-09-30Updated: 2012-10-19